EN Official Journal of the European Union C 306/6

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2014

(2015/C 306/08)

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January – 30 June 2014, at their meeting on 12 December 2014:

Annex I List of new marketing authorisations Annex II List of renewed marketing authorisations Annex III List of extended marketing authorisations Annex IV List of withdrawn marketing authorisations Annex V List of suspended marketing authorisations

ANNEX I List of new marketing authorisations The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January – 30 June 2014: EU Number Product Country Date of authorisation EU/1/06/361 Luminity Iceland 5.6.2014 EU/1/06/367 Diacomit Liechtenstein 28.2.2014 EU/1/12/767 Nimenrix Liechtenstein 30.6.2014 EU/1/13/834 Zoledronic Acid Accord Iceland 7.2.2014 EU/1/13/834 Zoledronic acid Accord Liechtenstein 28.2.2014 EU/1/13/834 Zoledronic acid Accord Norway 29.1.2014 EU/1/13/837 Tecfidera Iceland 11.2.2014 EU/1/13/837 Tecfidera Liechtenstein 28.2.2014 EU/1/13/837 Tecfidera Norway 5.2.2014 EU/1/13/856 Lonquex Liechtenstein 30.4.2014 EU/1/13/875 Deltyba Iceland 23.5.2014 EU/1/13/875 Deltyba Liechtenstein 30.6.2014 EU/1/13/875 Deltyba Norway 9.5.2014 EU/1/13/887 Fluenz Tetra Iceland 3.1.2014 EU/1/13/887 Fluenz Tetra Liechtenstein 28.2.2014 EU/1/13/887 Fluenz Tetra Norway 9.1.2014 EU/1/13/889 Levetiracetam Hospira Iceland 15.1.2014 EU/1/13/889 Levetiracetam Hospira Liechtenstein 28.2.2014 EU/1/13/889 Levetiracetam Hospira Norway 21.1.2014 EU/1/13/890 Cometriq Iceland 8.4.2014 EU/1/13/890 Cometriq Liechtenstein 30.4.2014 EU/1/13/890 Cometriq Norway 11.4.2014 EU/1/13/891 Brintellix Iceland 13.1.2014 EU/1/13/891 Brintellix Liechtenstein 28.2.2014 EU/1/13/891 Brintellix Norway 17.1.2014 EU/1/13/892 Tivicay Iceland 6.2.2014 EU/1/13/892 Tivicay Liechtenstein 28.2.2014 EU/1/13/892 Tivicay Norway 28.1.2014 EU/1/13/893 Opsumit Iceland 14.1.2014 EU/1/13/893 Opsumit Norway 17.1.2014 EU/1/13/894 Sovaldi Iceland 6.2.2014 EU/1/13/894 Sovaldi Liechtenstein 28.2.2014 EU/1/13/894 Sovaldi Norway 29.1.2014 EU/1/13/895 Cholic acid FGK Iceland 15.4.2014 EU/1/13/895 Cholic Acid FGK Liechtenstein 30.4.2014 EU/1/13/895 Kolsyre FGK Norway 28.4.2014 EU/1/13/896 Para-aminosalicylic acid Lucane Iceland 7.5.2014 EU/1/13/896 Para-aminosalicylic acid Lucane Liechtenstein 30.4.2014 EU/1/13/896 Granupas Norway 13.5.2014 EU/1/13/898 Anoro Liechtenstein 30.6.2014 EU/1/13/899 Laventair Liechtenstein 30.6.2014 EU/1/13/900 Xigduo Iceland 6.2.2014 EU/1/13/900 Xigduo Liechtenstein 28.2.2014 EU/1/13/900 Xigduo Norway 28.1.2014 EU/1/13/901 SIRTURO Iceland 4.4.2014 EU/1/13/901 Sirturo Liechtenstein 30.4.2014 EU/1/13/901 Sirturo Norway 14.3.2014 EU/1/13/904 Mirvaso Iceland 20.3.2014 EU/1/13/904 Mirvaso Liechtenstein 28.2.2014 EU/1/13/904 Mirvaso Norway 17.3.2014 EU/1/13/905 IZBA Iceland 18.3.2014 EU/1/13/905 Izba Liechtenstein 28.2.2014 EU/1/13/905 Izba Norway 17.3.2014 EU/1/13/906 Neuraceq Iceland 20.3.2014 EU/1/13/906 Neuraceq Liechtenstein 28.2.2014 EU/1/13/906 Neuraceq Norway 24.3.2014 EU/1/13/907 Adempas Iceland 8.4.2014 EU/1/13/907 Adempas Liechtenstein 30.4.2014 EU/1/13/907 Adempas Norway 7.4.2014 EU/1/13/908 Eperzan Iceland 9.4.2014 EU/1/13/908 Eperzan Liechtenstein 30.4.2014 EU/1/13/908 Eperzan Norway 15.4.2014 EU/1/13/909 Bemfola Iceland 14.4.2014 EU/1/13/909 Bemfola Liechtenstein 30.4.2014 EU/1/13/909 Bemfola Norway 25.4.2014 EU/1/14/898 ANORO Iceland 27.5.2014 EU/1/14/898 Anoro Norway 28.5.2014 EU/1/14/899 Laventair Iceland 27.5.2014 EU/1/14/899 Laventair Norway 4.6.2014 EU/1/14/911 Rivastigmine 3M Health Care Ltd. Iceland 14.4.2014 EU/1/14/911 Rivastigmin 3M Health Care Ltd. Liechtenstein 30.4.2014 EU/1/14/911 Rivastigmine 3M Health Care Ltd. Norway 14.4.2014 EU/1/14/912 Zoledronic acid Teva Generics Iceland 10.4.2014 EU/1/14/912 Zoledronic acid Teva Generics Liechtenstein 30.4.2014 EU/1/14/912 Zoledronic acid Teva Generics Norway 15.4.2014 EU/1/14/913 Latuda Iceland 8.4.2014 EU/1/14/913 Latuda Liechtenstein 30.4.2014 EU/1/14/913 Latuda Norway 8.4.2014 EU/1/14/914 Vimizim Iceland 23.5.2014 EU/1/14/914 Vimizim Liechtenstein 30.6.2014 EU/1/14/914 Vimizim Norway 23.5.2014 EU/1/14/915 Ebilfumin Iceland 5.6.2014 EU/1/14/915 Ebilfumin Liechtenstein 30.6.2014 EU/1/14/915 Ebilfumin Norway 18.6.2014 EU/1/14/916 Pregabalin Pfizer Iceland 7.5.2014 EU/1/14/916 Pregabalin Pfizer Liechtenstein 30.4.2014 EU/1/14/916 Pregabalin Pfizer Norway 13.5.2014 EU/1/14/917 Ulunar Breezhaler Liechtenstein 30.6.2014 EU/1/14/917 Ulunar Breezhaler Norway 21.5.2014 EU/1/14/918 Vokanamet Iceland 12.5.2014 EU/1/14/918 Vokanamet Liechtenstein 30.4.2014 EU/1/14/918 Vokanamet Norway 29.4.2014 EU/1/14/919 Hemangiol Iceland 12.5.2014 EU/1/14/919 Hemangiol Liechtenstein 30.4.2014 EU/1/14/919 Hemangiol Norway 8.5.2014 EU/1/14/920 DuoResp Spiromax Iceland 22.5.2014 EU/1/14/920 DuoResp Spiromax Liechtenstein 30.6.2014 EU/1/14/920 DuoResp Spiromax Norway 22.5.2014 EU/1/14/921 BiResp Spiromax Iceland 23.5.2014 EU/1/14/921 BiResp Spiromax Liechtenstein 30.6.2014 EU/1/14/921 BiResp Spiromax Norway 15.5.2014 EU/1/14/922 Incruse Iceland 22.5.2014 EU/1/14/922 Incruse Liechtenstein 30.6.2014 EU/1/14/922 Incruse Norway 22.5.2014 EU/1/14/923 Entyvio Iceland 5.6.2014 EU/1/14/923 Entyvio Liechtenstein 30.6.2014 EU/1/14/923 Entyvio Norway 17.6.2014 EU/1/14/924 OLYSIO Iceland 5.6.2014 EU/1/14/924 OLYSIO Liechtenstein 30.6.2014 EU/1/14/924 Olysio Norway 23.5.2014 EU/1/14/928 Sylvant Iceland 5.6.2014 EU/1/14/928 Sylvant Liechtenstein 30.6.2014 EU/1/14/928 Sylvant Norway 19.6.2014 EU/1/14/929 Revinty Ellipta Iceland 26.5.2014 EU/1/14/929 Revinty Ellipta Liechtenstein 30.6.2014 EU/1/14/929 Revinty Ellipta Norway 15.5.2014 EU/1/14/930 Jardiance Iceland 5.6.2014 EU/1/14/930 Jardiance Liechtenstein 30.6.2014 EU/1/14/930 Jardiance Norway 28.5.2014 EU/2/09/096 Leucogen Liechtenstein 30.6.2014 EU/2/09/103 Respiporc Flu3 Norway 13.2.2014 EU/2/12/138 RevitaCAM Liechtenstein 30.4.2014 EU/2/12/140 Poulvac E.coli Norway 7.4.2014 EU/2/13/151 Equilis West Nile Norway 7.4.2014 EU/2/13/153 Aftovaxpur Doe Norway 29.1.2014 EU/2/13/154 Apoquel Norway 21.1.2014 EU/2/13/155 Trifexis Norway 4.4.2014 EU/2/13/156 Vectra 3D Norway 4.4.2014 EU/2/13/157 Broadline Norway 24.3.2014 EU/2/13/158 Bravecto Iceland 28.2.2014 EU/2/13/158 Bravecto Liechtenstein 28.2.2014 EU/2/13/158 Bravecto Norway 21.3.2014 EU/2/13/159 NexGard Iceland 28.2.2014 EU/2/13/159 NexGard Liechtenstein 28.2.2014 EU/2/13/159 NexGard Norway 4.4.2014 EU/2/13/160 Fungitraxx Iceland 9.4.2014 EU/2/13/160 Fungitraxx Liechtenstein 30.4.2014 EU/2/13/160 Fungitraxx Norway 15.4.2014 EU/2/14/161 Equisolon Iceland 9.4.2014 EU/2/14/161 Equisolon Liechtenstein 30.4.2014 EU/2/14/161 Equisolon Norway 15.4.2014 EU/2/14/162 Parvoduk Iceland 9.5.2014 EU/2/14/162 Parvoduk Norway 6.6.2014 EU/2/14/163 Versican Plus DHPPi/L4R Iceland 6.6.2014 EU/2/14/164 Versican Plus DHPPi/L4 Iceland 6.6.2014 EU/2/14/164 Versican Plus DHPPi/L4 Liechtenstein 30.6.2014 EU/2/14/165 Vectra Felis Iceland 18.6.2014 EU/2/14/165 Vectra Felis Liechtenstein 30.6.2014

ANNEX II List of renewed marketing authorisations The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January – 30 June 2014: EU Number Product Country Date of authorisation EU/1/03/265 Bonviva Iceland 9.1.2014 EU/1/03/265 Bonviva Norway 16.1.2014 EU/1/03/265 Bonviva Liechtenstein 28.2.2014 EU/1/03/271 Advate Iceland 15.1.2014 EU/1/03/271 Advate Norway 17.1.2014 EU/1/03/271 Advate Liechtenstein 28.2.2014 EU/1/04/274 Velcade Norway 30.1.2014 EU/1/04/274 Velcade Iceland 5.2.2014 EU/1/04/287 Osseor Norway 18.6.2014 EU/1/04/287 Osseor Liechtenstein 30.6.2014 EU/1/04/288 Protelos Norway 18.6.2014 EU/1/04/288 Protelos Liechtenstein 30.6.2014 EU/1/04/289 Angiox Liechtenstein 30.6.2014 EU/1/06/367 Diacomit Norway 17.1.2014 EU/1/06/367 Diacomit Iceland 15.1.2014 EU/1/07/423 Vectibix Liechtenstein 28.2.2014 EU/1/07/423 Vectibix Norway 17.3.2014 EU/1/07/423 Vectibix Iceland 17.3.2014 EU/1/07/436 Isentress Norway 22.5.2014 EU/1/07/436 Isentress Iceland 26.5.2014 EU/1/07/436 Isentress Liechtenstein 30.6.2014 EU/1/07/440 Tyverb Iceland 19.3.2014 EU/1/07/440 Tyverb Norway 19.3.2014 EU/1/07/440 Tyverb Liechtenstein 30.4.2014 EU/1/08/497 Nplate Iceland 14.1.2014 EU/1/08/497 Nplate Norway 17.1.2014 EU/1/08/497 Nplate Liechtenstein 28.2.2014 EU/1/08/501 Ixiaro Iceland 18.3.2014 EU/1/08/501 Ixiaro Norway 25.3.2014 EU/1/08/501 Ixiaro Liechtenstein 30.4.2014 EU/1/08/502 Mepact Iceland 13.1.2014 EU/1/08/502 Mepact Norway 16.1.2014 EU/1/08/502 Mepact Liechtenstein 28.2.2014 EU/1/09/508 Synflorix Liechtenstein 28.2.2014 EU/1/09/508 Synflorix Iceland 18.3.2014 EU/1/09/508 Synflorix Norway 24.3.2014 EU/1/09/509 Ribavirin Teva Norway 29.1.2014 EU/1/09/509 Ribavirin Teva Iceland 6.2.2014 EU/1/09/509 Ribavirin Teva Liechtenstein 28.2.2014 EU/1/09/510 Fertavid Liechtenstein 28.2.2014 EU/1/09/510 Fertavid Norway 17.3.2014 EU/1/09/510 Fertavid Iceland 18.3.2014 EU/1/09/511 Conbriza Norway 17.3.2014 EU/1/09/512 Removab Iceland 10.1.2014 EU/1/09/512 Removab Norway 20.1.2014 EU/1/09/512 Removab Liechtenstein 28.2.2014 EU/1/09/514 Zebinix Norway 3.2.2014 EU/1/09/514 Zebinix Iceland 5.2.2014 EU/1/09/514 Zebinix Liechtenstein 28.2.2014 EU/1/09/515 CONTROLOC Control Liechtenstein 28.2.2014 EU/1/09/515 CONTROLOC Control Iceland 18.3.2014 EU/1/09/515 Controloc Control Norway 20.3.2014 EU/1/09/516 SOMAC Control Liechtenstein 28.2.2014 EU/1/09/516 SOMAC Control Iceland 18.3.2014 EU/1/09/516 Somac Control Norway 20.3.2014 EU/1/09/517 PANTOZOL Control Liechtenstein 28.2.2014 EU/1/09/517 PANTOZOL Control Iceland 18.3.2014 EU/1/09/517 Pantozol Control Norway 20.3.2014 EU/1/09/518 PANTECTA Control Liechtenstein 28.2.2014 EU/1/09/518 PANTECTA Control Iceland 18.3.2014 EU/1/09/518 Pantecta Control Norway 20.3.2014 EU/1/09/519 PANTOLOC Control Liechtenstein 28.2.2014 EU/1/09/519 PANTOLOC Control Iceland 18.3.2014 EU/1/09/519 Pantoloc Control Norway 20.3.2014 EU/1/09/521 Renvela Iceland 10.4.2014 EU/1/09/521 Renvela Norway 23.4.2014 EU/1/09/521 Renvela Liechtenstein 30.4.2014 EU/1/09/522 ellaOne Iceland 10.4.2014 EU/1/09/522 ellaOne Norway 25.4.2014 EU/1/09/522 ellaOne Liechtenstein 30.4.2014 EU/1/09/523 Modigraf Liechtenstein 28.2.2014 EU/1/09/523 Modigraf Iceland 12.3.2014 EU/1/09/523 Modigraf Norway 17.3.2014 EU/1/09/524 Qutenza Liechtenstein 30.4.2014 EU/1/09/524 Qutenza Norway 9.5.2014 EU/1/09/524 Qutenza Iceland 14.5.2014 EU/1/09/525 Nimvastid Norway 29.1.2014 EU/1/09/525 Nimvastid Iceland 5.2.2014 EU/1/09/525 Nimvastid Liechtenstein 28.2.2014 EU/1/09/526 Iressa Iceland 9.5.2014 EU/1/09/526 Iressa Norway 20.5.2014 EU/1/09/526 Iressa Liechtenstein 30.6.2014 EU/1/09/527 Ribavirin Teva Pharma BV Norway 29.1.2014 EU/1/09/527 Ribavirin Teva Pharma B.V. Iceland 6.2.2014 EU/1/09/528 Peyona Norway 17.3.2014 EU/1/09/528 Peyona Iceland 19.3.2014 EU/1/09/528 Peyona Liechtenstein 30.4.2014 EU/1/09/529 Victoza Norway 25.4.2014 EU/1/09/529 Victoza Liechtenstein 30.4.2014 EU/1/09/529 Victoza Iceland 9.5.2014 EU/1/09/530 Repaglinide Teva Liechtenstein 30.6.2014 EU/1/09/531 Instanyl Norway 29.4.2014 EU/1/09/531 Instanyl Liechtenstein 30.4.2014 EU/1/09/531 Instanyl Iceland 13.5.2014 EU/1/09/532 Clopidogrel Acino Iceland 10.4.2014 EU/1/09/532 Clopidogrel Acino Norway 11.4.2014 EU/1/09/532 Clopidogrel Acino Liechtenstein 30.4.2014 EU/1/09/533 Vedrop Norway 9.5.2014 EU/1/09/533 Vedrop Iceland 22.5.2014 EU/1/09/535 Grepid Norway 28.4.2014 EU/1/09/535 Grepid Liechtenstein 30.4.2014 EU/1/09/535 Grepid Iceland 9.5.2014 EU/1/09/536 Topotecan Actavis Iceland 20.6.2014 EU/1/09/536 Topotecan Actavis Norway 25.6.2014 EU/1/09/536 Topotecan Actavis Liechtenstein 30.6.2014 EU/1/09/537 Mozobil Norway 28.4.2014 EU/1/09/537 Mozobil Liechtenstein 30.4.2014 EU/1/09/537 Mozobil Iceland 9.5.2014 EU/1/09/538 Afinitor Iceland 6.6.2014 EU/1/09/538 Afinitor Norway 18.6.2014 EU/1/09/539 Samsca Liechtenstein 30.6.2014 EU/1/09/540 Clopidogrel Teva Norway 26.5.2014 EU/1/09/540 Clopidogrel Teva Iceland 6.6.2014 EU/1/09/540 Clopidogrel Teva Liechtenstein 30.6.2014 EU/1/09/541 Clopidogrel ratiopharm GmbH Norway 3.6.2014 EU/1/09/541 Clopidogrel ratiopharm GmbH Iceland 6.6.2014 EU/1/09/541 Clopidogrel ratiopharm GmbH Liechtenstein 30.6.2014 EU/1/09/544 Cimzia Iceland 6.6.2014 EU/1/09/544 Cimzia Norway 18.6.2014 EU/1/09/544 Cimzia Liechtenstein 30.6.2014 EU/1/09/546 Simponi Liechtenstein 30.6.2014 EU/1/09/550 Javlor Norway 18.6.2014 EU/1/09/550 Javlor Liechtenstein 30.6.2014 EU/1/09/551 Vizarsin Norway 26.5.2014 EU/1/09/551 Vizarsin Iceland 6.6.2014 EU/1/09/551 Vizarsin Liechtenstein 30.6.2014 EU/1/09/552 Topotecan Teva Liechtenstein 30.6.2014 EU/1/09/553 Zyllt Iceland 26.5.2014 EU/1/09/553 Zyllt Norway 26.5.2014 EU/1/09/553 Zyllt Liechtenstein 30.6.2014 EU/1/09/555 Clopidogrel TAD Liechtenstein 30.6.2014 EU/1/09/556 Clopidogrel Krka Iceland 26.5.2014 EU/1/09/556 Clopidogrel Krka Norway 26.5.2014 EU/1/09/556 Clopidogrel Krka Liechtenstein 30.6.2014 EU/1/09/558 Zylagren Norway 20.5.2014 EU/1/09/558 Zylagren Iceland 26.5.2014 EU/1/09/558 Zylagren Liechtenstein 30.6.2014 EU/1/09/559 Clopidogrel Mylan Iceland 6.6.2014 EU/1/09/559 Clopidogrel Mylan Liechtenstein 30.6.2014 EU/1/09/560 Clopidogrel dura Iceland 6.6.2014 EU/1/09/560 Clopidogrel DURA Liechtenstein 30.6.2014 EU/1/09/561 Clopidogrel Teva Pharma Iceland 26.5.2014 EU/1/09/561 Clopidogrel Teva Pharma Norway 26.5.2014 EU/1/09/561 Clopidogrel Teva Pharma Liechtenstein 30.6.2014 EU/1/09/562 Clopidogrel Krka d.d. Liechtenstein 30.6.2014 EU/1/09/564 Ilaris Liechtenstein 30.6.2014 EU/1/09/571 Pandemic Influenza Vaccine H5N1 Baxter Iceland 26.5.2014 EU/1/09/571 Pandemic influenza vaccine H5N1 Baxter Norway 26.5.2014 EU/1/09/571 Pandemic influenza vaccine H5N1 BAXTER Liechtenstein 30.6.2014 EU/1/09/581 Resolor Iceland 19.6.2014 EU/1/09/581 Resolor Liechtenstein 30.6.2014 EU/1/10/625 Arzerra Norway 28.1.2014 EU/1/10/625 Arzerra Iceland 12.2.2014 EU/1/10/625 Arzerra Liechtenstein 28.2.2014 EU/1/11/699 Fampyra Iceland 6.6.2014 EU/1/11/699 Fampyra Norway 18.6.2014 EU/1/11/699 Fampyra Liechtenstein 30.6.2014 EU/1/11/749 Caprelsa Iceland 15.1.2014 EU/1/11/749 Caprelsa Norway 20.1.2014 EU/1/11/749 Caprelsa Liechtenstein 28.2.2014 EU/1/12/764 Pixuvri Iceland 7.5.2014 EU/1/12/764 Pixuvri Norway 20.5.2014 EU/1/12/764 Pixuvri Liechtenstein 30.6.2014 EU/1/13/818 Bosulif Liechtenstein 28.2.2014 EU/1/13/818 Bosulif Norway 17.3.2014 EU/1/13/818 Bosulif Iceland 17.3.2014 EU/1/99/103 ReFacto AF Iceland 12.2.2014 EU/1/99/110 Sustiva Liechtenstein 30.4.2014 EU/1/99/110 Sustiva Norway 7.5.2014 EU/1/99/110 Sustiva Iceland 14.5.2014 EU/1/99/111 Stocrin Liechtenstein 30.4.2014 EU/1/99/111 Stocrin Norway 7.5.2014 EU/1/99/111 Stocrin Iceland 14.5.2014 EU/1/99/112 Ziagen Iceland 8.4.2014 EU/1/99/112 Ziagen Norway 15.4.2014 EU/1/99/112 Ziagen Liechtenstein 30.4.2014 EU/1/99/114 Zeffix Liechtenstein 30.6.2014 EU/2/04/042 Novem Norway 14.2.2014 EU/2/04/043 Equilis StrepE Iceland 7.5.2014 EU/2/04/043 Equilis StrepE Liechtenstein 30.6.2014 EU/2/06/070 Meloxidyl Norway 13.2.2014 EU/2/07/071 Slentrol Norway 13.2.2014 EU/2/08/080 Reconcile Norway 13.2.2014 EU/2/08/084 Trocoxil Norway 13.2.2014 EU/2/08/085 Easotic Norway 7.2.2014 EU/2/08/088 Acticam Iceland 6.1.2014 EU/2/08/088 Acticam Norway 29.1.2014 EU/2/08/088 Acticam Liechtenstein 28.2.2014 EU/2/08/089 Onsior Norway 17.3.2014 EU/2/08/090 Loxicom Iceland 19.3.2014 EU/2/08/090 Loxicom Norway 23.4.2014 EU/2/08/090 Loxicom Liechtenstein 30.4.2014 EU/2/08/091 Porcilis PCV Iceland 8.1.2014 EU/2/08/091 Porcilis PCV Norway 13.2.2014 EU/2/08/092 Startvac Liechtenstein 28.2.2014 EU/2/08/092 Startvac Iceland 28.2.2014 EU/2/08/092 Startvac Norway 23.4.2014 EU/2/09/094 BTVPUR AISap 8 Iceland 19.3.2014 EU/2/09/094 BTVPUR AlSap 8 Liechtenstein 30.4.2014 EU/2/09/095 Improvac Liechtenstein 30.4.2014 EU/2/09/095 Improvac Iceland 7.5.2014 EU/2/09/096 Leucogen Iceland 20.6.2014 EU/2/09/097 Leucofeligen FeLV/RCP Iceland 19.6.2014 EU/2/09/097 Leucofeligen FeLV/RCP Liechtenstein 30.6.2014 EU/2/09/098 Melovem Iceland 20.6.2014 EU/2/09/098 Melovem Liechtenstein 30.6.2014 EU/2/09/099 Suvaxyn PCV Iceland 19.6.2014 EU/2/09/099 Suvaxyn PCV Liechtenstein 30.6.2014 EU/2/98/006 Nobilis Norway 13.2.2014 EU/2/99/014 Stronghold Norway 19.2.2014 EU/2/99/015 Oxyglobin Norway 19.2.2014

ANNEX III List of extended marketing authorisations The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January – 30 June 2014: EU Number Product Country Date of authorisation EU/1/5/320 Noxafil Norway 21.5.2014 EU/1/5/320/002-003 Noxafil Iceland 14.5.2014 EU/1/08/492 RoActemra Norway 19.5.2014 EU/1/08/492/007 RoActemra Iceland 22.5.2014 EU/1/11/710/009-015 Votubia Iceland 20.1.2014 EU/1/13/825 Imatinib Actavis Norway 23.6.2014 EU/1/13/825/020-023 Imatinib Actavis Iceland 27.6.2014 EU/1/98/067 MabThera Norway 11.4.2014 EU/1/98/067/003 MabThera Iceland 9.4.2014 EU/2/04/044 Aivlosin Norway 17.3.2014 EU/2/09/098 Melovem Norway 11.2.2014 EU/2/10/115 Comfortis Norway 29.1.2014 EU/2/12/144 Contacera Norway 21.3.2014 EU/2/12/144/05-006 Contacera Iceland 12.3.2014

ANNEX IV List of withdrawn marketing authorisations The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January – 30 June 2014: EU Number Product Country Date of withdrawal EU/1/00/153 Infanrix Penta Iceland 22.1.2014 EU/1/06/339 Preotact Liechtenstein 30.6.2014 EU/1/06/349 Avaglim Iceland 21.1.2014 EU/1/06/381 Daronrix Iceland 21.1.2014 EU/1/09/554 Clopidogrel ratiopharm Iceland 21.1.2014 EU/1/09/554 Clopidogrel ratiopharm Norway 11.2.2014 EU/1/10/626 Ribavirin BioPartners Iceland 24.1.2014 EU/1/11/729 Onduarp Liechtenstein 28.2.2014 EU/1/11/729 Onduarp Iceland 12.3.2014 EU/1/11/729 Onduarp Norway 27.3.2014 EU/1/96/014 Tritanrix HepB Iceland 7.2.2014 EU/1/97/54 Viracept Iceland 24.1.2014 EU/2/00/022 Ibaflin Iceland 21.1.2014 EU/2/06/58 Flexicam Liechtenstein 30.6.2014 EU/2/06/58 Flexicam Norway 3.6.2014 EU/2/09/093 Netvax Norway 7.1.2014